36
Views
58
CrossRef citations to date
0
Altmetric
Cell Growth and Development

axl, a Transforming Gene Isolated from Primary Human Myeloid Leukemia Cells, Encodes a Novel Receptor Tyrosine Kinase

, , , , , , , , & show all
Pages 5016-5031 | Received 23 May 1991, Accepted 05 Jul 1991, Published online: 31 Mar 2023

References

  • Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York.
  • Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by point mutations altering the transmembrane domain of p185. Cell 45:649-657.
  • Basier, K., and E. Hafen. 1988. Control of photoreceptor cell fate by the sevenless protein requires a functional tyrosine kinase domain. Cell 54:299-311.
  • Bates, P. 1987. Double cos site vectors: simplified cosmid cloning. Methods Enzymol. 153:82-94.
  • Bazan, J. F. 1990. Structural design and molecular evolution of a cytokine receptor family. Proc. Natl. Acad. Sci. USA 87:6934-6938.
  • Birchmeier, C., K. O’Neill, M. Riggs, and M. Wigler. 1990. Characterization of ROS1 cDNA from a human glioblastoma cell line. Proc. Natl. Acad. Sci. USA 87:4799-4803.
  • Bottaro, D. P., J. S. Rubin, D. L. Faletto, A. M.-L. Chan, T. E. Kmiecik, G. F. Vande Woude, and S. A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804.
  • Cantley, L. C., K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell 64:281-302.
  • Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
  • Cooper, C. S., M. Park, D. G. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and G. F. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically-transformed human cell line. Nature (London) 311:29-33.
  • Coussens, L., C. Van Beveren, D. Smith, E. Chen, R. L. Mitchell, C. M. Isacke, I. M. Verma, and A. Ullrich. 1986. Structural alteration of a viral homologue of receptor protooncogene fins at the carboxyl terminus. Nature (London) 320:277-280.
  • Cross, M., and T. M. Dexter. 1991. Growth factors in development, transformation, and tumorigenesis. Cell 64:271-280.
  • Daley, G. Q., R. A. Van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247:824-830.
  • Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
  • Di Fiore, P. P., J. H. Pierce, T. P. Fleming, R. Hazan, A. Ullrich, C. R. King, J. Schlesinger, S. A. Aaronson, and H. N. Antoniades. 1987. Overexpression of the human EGF receptor confers and EGF-dependent transformed phenotype to NIH/3T3 cells. Cell 51:1063-1070.
  • Di Fiore, P. P., J. H. Pierce, M. H. Kraus, O. Segatto, C. R. King, and S. A. Aaronson. 1987. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178-182.
  • Dionne, C. A., G. Crumley, F. Bellot, J. M. Kaplow, G. Searfoss, M. Ruta, W. H. Burgess, M. Jaye, and J. Schlesinger. 1990. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 6:3341-3351.
  • Downward, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature (London) 307:521-527.
  • Ebina, Y., L. Ellis, K. Jarnagin, M. Edery, L. Graf, E. Clauser, J.-H. Ou, F. Masiarz, Y. W. Kan, I. D. Goldfine, R. A. Roth, and W. J. Rutter. 1985. The human insulin receptor cDNA: the structural basis for hormone-activated membrane signalling. Cell 40:747-758.
  • Elefanty, A. G., I. K. Hariharan, and S. Cory. 1990. Bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J. 9:1069.
  • Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
  • Furley, A. J., S. B. Morton, D. Manalo, D. Karagogeos, J. Dodd, and T. M. Jessell. 1990. The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity. Cell 61:157-170.
  • Glisin, V., R. Crkvenjakov, and C. Byus. 1974. Ribonucleic acid isolation by cesium chloride centrifugation. Biochemistry 13:2633-2637.
  • Grieco, M., M. Santoro, M. T. Berlingieri, R. M. Melillo, R. Donghi, I. Bongarzone, M. A. Pierotti, G. Della Porta, A. Fusco, and G. Vecchio. 1990. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human papillary carcinomas. Cell 60:557-563.
  • Gronwald, R. G. K., F. J. Grant, B. A. Haldeman, C. E. Hart, P. J. O’Hara, F. S. Hagen, R. Ross, D. F. Bowen-Pope, and M. J. Murray. 1988. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc. Natl. Acad. Sci. USA 85:3435-3439.
  • Gubler, U., and B. J. Hoffman. 1983. A simple and very efficient method for generating cDNA libraries. Gene 25:263-269.
  • Hanks, H. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52.
  • Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Harrelson, A. L., and C. S. Goodman. 1988. Growth cone guidance in insects: fasciclin II is a member of the immunoglobulin superfamily. Science 242:700-708.
  • Heisterkamp, N., G. Jenster, J. ten-Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukaemia in bcr/abl transgenic mice. Nature (London) 344:251-253.
  • Henikoff, S. 1987. Unidirectional digestion with exonuclease III in DNA sequence analysis. Methods Enzymol. 155:156-165.
  • Hirai, H., Y. Maru, K. Hagiwara, J. Nishida, and F. Takaku. 1987. A novel putative tyrosine kinase encoded by the eph gene. Science 238:1717-1720.
  • Holt, J. T., C. C. Morton, A. W. Nienhuis, and P. Leder. 1987. Molecular mechanisms of hematological neoplasms, p. 347-376. In G. Stamatoyannopoulos, A. W. Nienhuis, P. Leder, and P. W. Majerus (ed.), The molecular basis of blood diseases. W. B. Saunders Co., Philadelphia.
  • Hsieh, P., and P. W. Robbins. 1984. Regulation of asparagine-linked oligosaccharide processing. J. Biol. Chem. 259:2375-2382.
  • Jansen, R., and F. D. Ledley. 1989. Production of discrete high specific activity DNA probes using the polymerase chain reaction. Gene. Anal. Tech. 6:79-83.
  • Janssen, J., et al. Oncogene, in press.
  • Jarvis, D. L., and M. D. Summers. 1989. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. J. Virol. 61:3617-3620.
  • Jelinek, W. R., T. P. Toomey, L. Leinwand, C. H. Duncan, P. A. Biro, P. V. Choudary, S. M. Weissman, C. M. Rubin, C. M. Houck, and P. L. Schmid. 1980. Ubiquitous, interspersed repeated sequences in the human genome. Proc. Natl. Acad. Sci. USA 77:1398-1402.
  • Kaleko, M., W. J. Rutter, and A. D. Miller. 1990. Overexpression of the human insulinlike growth factor receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10:464-473.
  • Kaplan, D. R., B. L. Hempstead, D. Martin-Zanca, M. V. Chao, and L. F. Parada. 1991. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252:554-557.
  • Klein, R., S. Jing, V. Nanduri, E. O’Rourke, and M. Barbacid. 1991. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65:189-197.
  • Kornbluth, S., K. E. Paulson, and H. Hanafusa. 1988. Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries. Mol. Cell. Biol. 8:5541-5544.
  • Korneluk, R. G., H. L. McLeod, T. W. McKeithan, J. D. Brooks, and A. E. MacKenzie. 1989. A chromosome 19 clone from a translocation breakpoint shows close linkage and linkage disequilibrium with myotonic dystrophy. Genomics 4:146-151.
  • Kozak, M. 1987. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-8148.
  • Lhotak, V., P. Greer, K. Letwin, and T. Pawson. 1991. Characterization of Elk, a brain-specific receptor tyrosine kinase. Mol. Cell. Biol. 11:2496-2502.
  • Lichter, P., T. Cremer, J. Borden, L. Manuelides, and D. C. Ward. 1988. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80:224-234.
  • Lindberg, R. A., and T. Hunter. 1990. cDNA cloning and characterization of Eck, an epithelial cell receptor protein-tyrosine kinase in the Eph/Elk family of protein kinases. Mol. Cell. Biol. 10:6316-6324.
  • Liu, E., and B. Hjelle. Unpublished data.
  • Liu, E., B. Hjelle, and J. M. Bishop. 1988. Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 85:1952.
  • Marth, J. D., R. W. Overell, K. E. Meier, E. G. Krebs, and R. M. Perlmutter. 1988. Translational activation of the lck proto-oncogene. Nature (London) 332:171-173.
  • Martin-Zanca, D., S. H. Hughes, and M. Barbacid. 1986. A human oncogene formed by the fusion of truncated tropomyosin and tyrosine kinase sequences. Nature (London) 319:743-748.
  • Martin-Zanca, D., R. R. Oskam, G. Mitra, T. Copeland, and M. Barbacid. 1989. Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol. 9:24-33.
  • Maru, Y., H. Hirai, and F. Takaku. 1990. Overexpression confers an oncogenic potential upon the eph gene. Oncogene 5:445-447.
  • Matsushime, H., L. H. Wang, and M. Shibuya. 1986. Human c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptor-like molecule. Mol. Cell. Biol. 6:3000-3004.
  • McCune, B. K., and H. S. Earp. 1989. The epidermal growth factor receptor tyrosine kinase in liver epithelial cells. J. Biol. Chem. 264:15501-15507.
  • McKeithan, T. W., J. D. Rowley, T. B. Shows, and M. O. Diaz. 1987. Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 84:9257-9260.
  • Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
  • Miller, L. K. 1988. Baculoviruses are gene expression vectors. Annu. Rev. Microbiol. 42:177-199.
  • Neubauer, A., B. Neubauer, and E. Liu. 1990. Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interferon gene in chronic myelogenous leukemia. Nucleic Acids Res. 18:993-998.
  • Neubauer, A., J. P. O’Bryan, and E. Liu. Unpublished data.
  • Norton, P. A., R. O. Hynes, and D. J. G. Rees. 1990. sevenless: seven found? Cell 61:15-16.
  • O’Bryan, J. P., and E. Liu. Unpublished data.
  • Park, M., M. Dean, C. S. Cooper, M. Schmidt, S. J. O’Brien, D. G. Blair, and G. F. Vande Woude. 1986. Mechanism of met oncogene activation. Cell 45:895-904.
  • Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. Vande Woude. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379-6383.
  • Partanen, J., T. P. Makela, R. Alitalo, H. Lehvaslaiho, and K. Alitalo. 1990. Putative tyrosine kinases expressed in K-562 human leukemia cell. Proc. Natl. Acad. Sci. USA 87:8913-8917.
  • Patthy, L. 1990. Homology of a domain of the growth hormone/prolactin receptor family with type III modules of fibronectin. Cell 61:13-14.
  • Peterson, T. E., H. C. Thøgerson, K. Skorstengaard, K. Vibe-Pedersen, P. Sahl, L. Sottrup-Jensen, and S. Magnusson. 1983. Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc. Natl. Acad. Sci. USA 80:137-141.
  • Reddy, E. P., R. K. Reynolds, E. Santos, and M. Barbacid. 1982. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (London) 300:149.
  • Rowley, J. D., and J. R. Testa. 1982. Chromosome abnormalities in malignant hematologic disease. Adv. Cancer Res. 36:103-148.
  • Roussel, M. F., T. J. Dull, C. W. Rettenmier, P. Ralph, A. Ullrich, and C. Sherr. 1987. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (London) 325:549-552.
  • Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
  • Seino, S., and G. I. Bell. 1989. Alternative splicing of the human insulin receptor messenger RNA. Biochem. Biophys. Res. Commun. 159:312-316.
  • Sherr, C. J. 1990. Colony-stimulating factor-1 receptor. Blood 75:1-12.
  • Shier, P., and V. M. Watt. 1989. Primary structure of a putative receptor for a ligand of the insulin family. J. Biol. Chem. 264:14605-14608.
  • Shtivelman, E., B. Lifshitz, R. P. Gale, B. A. Roe, and E. Canaani. 1986. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277-284.
  • Skorstengaard, K., M. S. Jensen, P. Sahl, T. E. Petersen, and S. Magnusson. 1986. Complete primary structure of bovine plasma fibronectin. Eur. J. Biochem. 161:441-453.
  • Summers, M. D., and G. E. Smith. 1987. A manual of methods for baculovirus vectors and insect cell culture procedures. Bulletin no. 1555. Texas Agriculture Experiment Station and Texas A&M University, College Station.
  • Tabin, C. J., S. M. Bradley, C. I. Bargmann, R. A. Weinberg, Alex G. Papageorge, E. M. Scolnick, R. Dhar, D. R. Lowry, and E. H. Chang. 1982. Mechanism of activation of a human oncogene. Nature (London) 300:143-149.
  • Tetteroo, P. A., F. Massaro, A. Mulder, R. Schreuder-Van Gelder, and A. E. G. K. Von Dem Borne. 1984. Megakaryoblastic differentiation of proerythroblastic K562 cell line cells. Leukemia Res. 8:197-206.
  • Ullrich, A., A. Gray, A. W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Francke, J. Ramachandran, and Y. Fujita-Yamaguchi. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:2503-2512.
  • Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
  • Velu, T. J., L. Beguinot, W. C. Vass, M. C. Willingham, G. T. Merlino, I. Pastan, and D. R. Lowy. 1987. Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238:1408-1410.
  • von Heijne, G. 1984. How signal sequences maintain cleavage specificity. J. Mol. Biol. 173:243-251.
  • Williams, A. F., and A. N. Barclay. 1988. The immunoglobulin superfamily—domains for cell surface recognition. Annu. Rev. Immunol. 6:381-405.
  • Yarden, Y., W.-J. Kuang, T. Yang-Feng, L. Coussens, S. Munemitsu, T. J. Dull, E. Chen, J. Schlessinger, U. Francke, and A. Ullrich. 1987. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6:3341-3351.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.